EX-99.1 2 dp12865_ex9901.htm EXHIBIT 99.1

Exhibit 99.1
 
Press Release
www.shire.com
  
 
Notification of major interests in shares

March 19, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company
 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Shire plc

2. Reason for the notification
State
Yes/No
An acquisition or disposal of voting rights
Yes
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached
     
An event changing the breakdown of voting rights
  
Other (please specify):       
     

3. Full name of person(s) subject to the notification obligation:
Capital Group International, Inc.
4. Full name of shareholder(s) (if different from 3.):
  
5. Date of the transaction (and date on which the threshold is crossed
or reached if different):
17 March 2009
6. Date on which issuer notified:
18 March 2009
7. Threshold(s) that is/are crossed or reached:
 
Above 4%
8. Notified details:
     


A: Voting rights attached to shares

 
 
Class/type of shares
 if possible using the ISIN CODE
Situation previous to
the Triggering
transaction
Resulting situation after the triggering
transaction
Number
of
Shares
Number
of
Voting
Rights
Number
of
shares
Number of voting
rights
% of voting
rights
     
Direct
Indirect
Direct
Indirect
Direct
Indirect
Ordinary Shares
(JE00B2QKY057)
9,926,021
9,926,021
  
10,785,821
  
10,785,821
  
1.9253%
ADRs
(US82481R1068)
4,059,100
12,177,300
  
4,209,100
  
12,627,300
  
2.2540%


B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument
Expiration
date
Exercise/Conversion
Period/ Date
Number of voting
rights that may be
acquired if  the instrument
is exercised/converted
% of voting
rights
     
     
     
     
     
 
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
 
 
 
 
 

 
Total (A+B)
  
Number of voting rights
% of voting rights
23,413,121
4.1793%


9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 
Number of Shares
Percent of Outstanding
Capital Group International Inc (CGII) Holdings
23,413,121
4.179%
     
Holdings by CGII Management Companies and Funds:
    
     
Capital Guardian Trust Company
19,574,721
3.494%
     
Capital International Limited
     591,600
0.106%
     
Capital International Sárl
     606,600
0.108%
     
Capital International Inc.
  2,640,200
0.471%

Proxy Voting:

10. Name of the proxy holder:
N/A
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A

13. Additional information:
Notification using the total voting rights figures of 560,222,583
 
 
14. Contact name:
Gina Martinez/Vivien Tan
15. Contact telephone number:
(213) 615-0469

Contact at Shire plc: Tony Guthrie, Deputy Company Secretary, 01256 894746
 
For further information please contact:

Investor Relations
Cléa Rosenfeld (Rest of the World)
+44 1256 894 160
 
Eric Rojas (North America)
+1 617 551 9715

Notes to editors

SHIRE PLC
Shire’s strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.  Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions.  Shire’s in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights.  Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company’s website: www.shire.com.